Assessing Surmodics: Insights From 5 Financial Analysts
Assessing Surmodics: Insights From 5 Financial Analysts
評估Surmodics：來自5位金融分析師的見解
Surmodics (NASDAQ:SRDX) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
在過去的三個月中，有5位分析師對Surmodics（納斯達克股票代碼：SRDX）進行了分析，揭示了從看漲到看跌的不同觀點。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表簡要介紹了他們最近的收視率，展示了過去30天中不斷變化的情緒，並將其與前幾個月進行了比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $49.4, a high estimate of $71.00, and a low estimate of $43.00. Experiencing a 16.27% decline, the current average is now lower than the previous average price target of $59.00.
分析師分析的12個月目標股價提供了見解，平均目標價爲49.4美元，最高估計爲71.00美元，低估值爲43.00美元。目前的平均價格下降了16.27％，現在低於之前的平均目標股價59.00美元。
Diving into Analyst Ratings: An In-Depth Exploration
深入分析師評級：深度探索
The perception of Surmodics...
通過最近...
登入免費觀看全文
登入/註冊